WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • WJPPS: MARCH ISSUE PUBLISHED
  • March Issue has been successfully launched on 1 March 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

Abstract

CASE STUDY ON PSEUDOBULBAR PALSY, A NEUROLIGICAL DISORDER- PATIENT MONITORING AND PATIENT COUNSELING BY CLINICAL PHARMACIST

Gowthami Padma Kurra*, Phanimala Kondeti, Sai Anusha Lakkoju and Dhanunjaya Rao Kolli

ABSTRACT

Pseudobulbar palsy is a medical disorder in which there is an inability to control facial movements such as chewing and speaking). It may occur in association with a variety of neurological diseases like amyotrophic lateral sclerosis, Parkinson’s disease, Alzheimer’s disease, stroke, CADASIL syndrome (cerebral autosomal dominant arteriopathy with sub cortical infarcts and leukoencephalopathy), brain injury and brain tumors. The psychological consequences and the impact on social interactions may commonly misidentify as a mood disorder, particularly depression or bipolar disorder. In pseudobulbar palsy the pathways involving serotonin and glutamate are disrupted. So the effective treatment for many years is with antidepressants like tricyclic antidepressants and SSRI’S (selective serotonin receptor inhibitors). But recently a new drug was approved by FDA Nuedexta a combination of dextromethorphan and quinidine as safe and effective for treating Pseudobulbar palsy.

Keywords: Pseudobulbar palsy, Amyotrophic Lateral sclerosis, Parkinson’s disease, Alzheimer’s disease, Nuedexta.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More